382 related articles for article (PubMed ID: 29109168)
1. Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection.
Micek ST; Hampton N; Kollef M
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109168
[TBL] [Abstract][Full Text] [Related]
2. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.
Zilberberg MD; Shorr AF; Micek ST; Vazquez-Guillamet C; Kollef MH
Crit Care; 2014 Nov; 18(6):596. PubMed ID: 25412897
[TBL] [Abstract][Full Text] [Related]
3. The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*.
Labelle A; Juang P; Reichley R; Micek S; Hoffmann J; Hoban A; Hampton N; Kollef M
Crit Care Med; 2012 Jul; 40(7):2016-21. PubMed ID: 22584765
[TBL] [Abstract][Full Text] [Related]
4. Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis.
Johnson MT; Reichley R; Hoppe-Bauer J; Dunne WM; Micek S; Kollef M
Crit Care Med; 2011 Aug; 39(8):1859-65. PubMed ID: 21499086
[TBL] [Abstract][Full Text] [Related]
5. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia.
Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Hoppe-Bauer J; Dunne WM; Kollef MH
J Hosp Med; 2011 Sep; 6(7):405-10. PubMed ID: 21916003
[TBL] [Abstract][Full Text] [Related]
6. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Kollef MH
Antimicrob Agents Chemother; 2010 May; 54(5):1742-8. PubMed ID: 20160050
[TBL] [Abstract][Full Text] [Related]
7. Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.
Fitzpatrick JM; Biswas JS; Edgeworth JD; Islam J; Jenkins N; Judge R; Lavery AJ; Melzer M; Morris-Jones S; Nsutebu EF; Peters J; Pillay DG; Pink F; Price JR; Scarborough M; Thwaites GE; Tilley R; Walker AS; Llewelyn MJ;
Clin Microbiol Infect; 2016 Mar; 22(3):244-51. PubMed ID: 26577143
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic-resistant Gram-negative bacteremia in pediatric oncology patients--risk factors and outcomes.
Haeusler GM; Mechinaud F; Daley AJ; Starr M; Shann F; Connell TG; Bryant PA; Donath S; Curtis N
Pediatr Infect Dis J; 2013 Jul; 32(7):723-6. PubMed ID: 23838774
[TBL] [Abstract][Full Text] [Related]
9. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
10. Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
Alves MD; Ribeiro VB; Tessari JP; Mattiello F; De Bacco G; Luz DI; Vieira FJ; Behle TF; Pasqualotto AC; Zavascki AP
J Antimicrob Chemother; 2014 Jun; 69(6):1681-7. PubMed ID: 24474430
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay.
Shorr AF; Micek ST; Welch EC; Doherty JA; Reichley RM; Kollef MH
Crit Care Med; 2011 Jan; 39(1):46-51. PubMed ID: 20890186
[TBL] [Abstract][Full Text] [Related]
12. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.
Vazquez-Guillamet C; Scolari M; Zilberberg MD; Shorr AF; Micek ST; Kollef M
Crit Care Med; 2014 Nov; 42(11):2342-9. PubMed ID: 25072764
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
[TBL] [Abstract][Full Text] [Related]
14. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
BMC Infect Dis; 2017 Apr; 17(1):279. PubMed ID: 28415969
[TBL] [Abstract][Full Text] [Related]
15. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
[TBL] [Abstract][Full Text] [Related]
16. An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis.
Micek S; Johnson MT; Reichley R; Kollef MH
BMC Infect Dis; 2012 Mar; 12():56. PubMed ID: 22414209
[TBL] [Abstract][Full Text] [Related]
17. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
18. Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay.
Scarsi KK; Feinglass JM; Scheetz MH; Postelnick MJ; Bolon MK; Noskin GA
Antimicrob Agents Chemother; 2006 Oct; 50(10):3355-60. PubMed ID: 17005817
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study.
Khan FY; Elshafie SS; Almaslamani M; Abu-Khattab M; El Hiday AH; Errayes M; Almaslamani E
Travel Med Infect Dis; 2010 Nov; 8(6):377-87. PubMed ID: 21074495
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
